Drug
Candesartan Cilexetil
Candesartan Cilexetil: highest development phase Phase 1, developed by AstraZeneca. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- AstraZeneca
Trials
| Drug | Phase | Indication |
|---|---|---|
| Candesartan cilexetil NCT00844324 | Phase 1 | Hypertension |
Latest
No recent events.
Follow Candesartan Cilexetil on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.